{
    "ticker": "SENS",
    "name": "Senseonics Holdings, Inc.",
    "description": "Senseonics Holdings, Inc. is a medical technology company focused on the development and commercialization of innovative glucose monitoring systems for people with diabetes. Founded in 2013 and headquartered in Germantown, Maryland, Senseonics is best known for its Eversense\u00ae continuous glucose monitoring (CGM) system, which features a unique implantable sensor that can be placed under the skin to provide real-time glucose readings for up to 90 days. This technology allows patients to manage their diabetes more effectively by providing accurate and continuous monitoring, leading to improved health outcomes. The Eversense system is designed to reduce the burden of diabetes management and offers features such as customizable alerts for high and low glucose levels, as well as smartphone connectivity for easy access to data. Senseonics aims to enhance the quality of life for individuals with diabetes through its cutting-edge technology, while also striving to meet the growing demand for innovative solutions in the diabetes care market. The company is committed to research and development, continuously seeking to improve its products and expand their availability to patients worldwide.",
    "industry": [
        "Medical Devices",
        "Healthcare"
    ],
    "headquarters": "Germantown, Maryland, USA",
    "founded": "2013",
    "website": "https://www.senseonics.com",
    "ceo": "Tim Goodnow",
    "social_media": {
        "twitter": "https://twitter.com/senseonics",
        "linkedin": "https://www.linkedin.com/company/senseonics/"
    },
    "investor_relations": "https://investors.senseonics.com",
    "key_executives": [
        {
            "name": "Tim Goodnow",
            "position": "CEO"
        },
        {
            "name": "Philip T. D. S. Dyer",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Continuous Glucose Monitoring",
            "products": [
                "Eversense\u00ae CGM System"
            ]
        }
    ],
    "seo": {
        "meta_title": "Senseonics Holdings, Inc. | Innovative Diabetes Management Solutions",
        "meta_description": "Learn about Senseonics Holdings, Inc., a leader in continuous glucose monitoring technology for diabetes management with the Eversense\u00ae system.",
        "keywords": [
            "Senseonics",
            "Continuous Glucose Monitoring",
            "Diabetes Care",
            "Eversense",
            "Medical Devices"
        ]
    },
    "faq": [
        {
            "question": "What is Senseonics known for?",
            "answer": "Senseonics is known for its innovative Eversense\u00ae continuous glucose monitoring system for diabetes management."
        },
        {
            "question": "Who is the CEO of Senseonics?",
            "answer": "Tim Goodnow is the CEO of Senseonics Holdings, Inc."
        },
        {
            "question": "Where is Senseonics headquartered?",
            "answer": "Senseonics is headquartered in Germantown, Maryland, USA."
        },
        {
            "question": "What is the Eversense\u00ae system?",
            "answer": "The Eversense\u00ae system is an implantable continuous glucose monitoring system that provides real-time glucose readings for up to 90 days."
        },
        {
            "question": "When was Senseonics founded?",
            "answer": "Senseonics was founded in 2013."
        }
    ],
    "competitors": [
        "DXCM",
        "ABT",
        "MDT"
    ],
    "related_stocks": [
        "AAPL",
        "GOOGL",
        "AMZN",
        "MSFT"
    ]
}